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States (US) known as the Gene-Environment Interactions in Ag-
ing, Functional Decline and Disease (GIAFD) family. Here we
elucidate the study design, and the relationship between clini-
cal phenotypes and biological markers for 365 members of this
extended family.
Methods: The GIAFD family pedigree encompasses 3357 indi-
viduals dating back nine generations in the US. Ascertainment
of 365 members was accomplished at three reunions between
2002, 2004 and 2006, and included blood sampling (n = 350),
physician-performed hand physical examinations for OA (n =
287), and extensive self-report of axial and appendicular joint
symptoms (n = 341). Several deﬁnitions of hand OA were em-
ployed for this study including modiﬁed ACR criteria, GoGo (Ge-
netics of Generalized Osteoarthritis) criteria, and any single hand
joint (either DIP or PIP or CMC) involvement. Comparator groups
were deﬁned as Non-hand OA (negative hand examination but
varying prevalence of joint symptoms), and Control (a subset
of the non-hand OA group with negative hand examination and
no joint symptoms). Seven OA-related serum biomarkers were
measured in 278 participants with available serum samples for:
PIIANP (LINCO), CPII (IBEX), C2C (IBEX), Cartilage Oligomeric
Matrix Protein or COMP (inhouse assay with monoclonal anti-
bodies 17C10 and 16F12 provided by Dr. V Vilim), HA (Cor-
genix), hs-CRP (MAGIWEL), and glycated protein (DIAZYME).
Biomarker data were natural logarithm (Ln) transformed to meet
assumptions of normalcy for statistical analysis, performed using
GraphPad Prism (GraphPad software, San Diego, CA) and JMP
(SAS, Cary, NC) software. Results were analyzed using oneway
ANOVA with Dunnett’s post hoc test (Hand OA designated the
reference group). A P-value of <0.05 was considered statistically
signiﬁcant.
Results: The sample of 278 examined participants consisted of
Figure 1. Relationships of OA biomarkers and sum of hand joint (DIP/PIP/CMC)
amount.
Abstract 112 – Table 1. Comparison of biomarkers between groups
Hand OA Non-Hand OA Controls
Modiﬁed hand ACR criteria
Ln HA 4.17 ±0.84 3.47±0.94** 3.08±1.01**
Ln PIIANP 6.94±1.10 7.14±0.67++
Age, years (n) 68.0±11.7 (38) 53.7±14.6** (240) 47.2±13.6** (41)
GoGo hand criterita
Ln HA 4.09±0.84 3.46±0.94** 3.07±1.01**
Ln PIIANP 7.00±1.38 7.11±0.63
Age, years (n) 67.4±12.0 (43) 53.5±14.5** (235) 47.2±13.6** (47)
Any single hand joint involvement
Ln HA 3.87±0.83 3.36±0.98** 3.08±1.01**
Ln COMP 7.50±0.40 7.35±0.47* 7.28±0.48*
Ln PIIANP 6.96±0.89 7.18±0.74+++
Age, years (n) 63.7±12.1 (110) 50.3±14.3** (168) 47.2±13.6** (47)
Values are mean ± SD. *p<0.05 and **p<0.01 compared with hand OA; ++p<0.01 and +++p<0.005 compared with hand OA adjusted for age and sex.
192 women and 86 men. Mean serum HA, COMP, CPII, and hs-
CRP were consistently higher in the OA group for all deﬁnitions of
hand OA; the mean biomarker concentration difference between
hand OA and non-hand OA groups was statistically signiﬁcant
for HA and COMP (Table 1). Adjusted for age and sex, the hand
OA group had signiﬁcantly lower mean serum levels of PIIANP
using two of the three hand OA deﬁnitions (Table 1). Finally,
a signiﬁcant dose response was observed for serum HA and
numbers of hand joints affected by OA (Figure 1).
Conclusions: We report the ﬁrst evidence to our knowledge for
an association of OA biomarkers and hand OA based on physical
examination alone. This study design offers the prospect of
minimizing genetic heterogeneity through the analysis of a large
family, and demonstrated here, the feasibility of utilizing several
OA-related biomarkers as quantitative traits to identify underlying
OA genes.
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Purpose: As proteins age they undergo non-enzymic post-
translation modiﬁcation including, isomerization, racemization
and deamidation. These changes accumulate with time in long
lived proteins and can potentially alter both their structure and
their properties. Cartilage is composed primarily of type II col-
lagen and proteoglycan with a few minor components. Many of
the proteins in cartilage are believed to be extremely long lived
(especially collagen) and so are likely to be susceptible to age
related modiﬁcations. In this project we have elected to study the
age related change isomerization, the spontaneous conversion
of α-aspartate (asp) to β-asp (IsoAsp), see Figure 1. The aims
of this current project are two fold: ﬁrstly to determine whether
IsoAsp can be detected in osteoarthritic cartilage, and secondly
to develop methods to identify speciﬁc sites of isomerization.
Methods: Human cartilage was collected from arthroplasty pa-
tients (n=17), aged 56 to 88, and either subjected to an EDTA
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extraction or pooled and subjected to sequential salt extraction to
purify the type II collagen. IsoAsp content was determined using
the PIMT assay (Promega).
Results: We identiﬁed PIMT activity in all of the EDTA extracts
we investigated suggesting the presence of widespread IsoAsp
(see Figure 2). We found no signiﬁcant difference (P=0.92) in
isoAsp content of cartilage comparing sites remote (28.4µM/g
cartilage, SEM 5.6) from the lesion to lesion sites (26.5µM/g
cartilage, SEM 4.8); we did ﬁnd a signiﬁcant difference (P=0.03)
between deep (99.9µM/g cartilage, SEM 31.7) and superﬁcial
cartilage (51.6µM/g cartilage, SEM 25.6) samples. We were also
able to measure isoAsp in paired synovial ﬂuid samples (mean
1.8µM/ml synovial ﬂuid, SEM 0.6). There were also detectable
levels of IsoAsp in our isolated and pooled type II collagen
fraction (mean 62.8pM/µg collagen).
As we identiﬁed signiﬁcant IsoAsp in cartilage we have inves-
tigated various ways of detecting IsoAsp hot spots. We have
modiﬁed the PIMT assay so that methyl groups are retained at
the IsoAsp location, Figure 3. We hope to use this approach in
conjunction with mass spectrometry to identify the corresponding
mass shifts in modiﬁed epitopes.
Conclusions: We have identiﬁed appreciable post-translational
damage in the form of IsoAsp in EDTA extracts of cartilage. We
were unable to identify differences in mean IsoAsp levels be-
tween cartilage lesions and sites remote from lesion suggesting
that apparently healthy appearing cartilage in an OA joint turns
over at rates similar to lesioned cartilage. We did however ﬁnd
a signiﬁcant difference between deep and superﬁcial cartilage
implying that the proteins deep within the cartilage had accu-
mulated more changes and so were older. We identiﬁed IsoAsp
in puriﬁed collagen suggesting that even this highly resistant
protein is susceptible to IsoAsp formation, which could lead to
instabilities in its structure with age. We have modiﬁed the PIMT
assay to retain a methyl group at IsoAsp sites and we hope to
develop this further to identify speciﬁc sites of isomerization.
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Purpose: To compare the levels of serum cartilage oligomeric
matrix protein (COMP) and aggrecan fetal epitope CS846,
two biochemical markers of cartilage degradation and abnor-
mal synthesis, respectively, between healthy volunteers, knee
osteoarthritis (OA) and anterior cruciate ligament (ACL) injury
patients.
Methods: Serum samples were collected at a single time point
from 36 patients divided into 3 groups: knee OA (N=12) mean
age (SD) 62.3 (8.5) yrs., ACL rupture (N=12) mean age 48.2
(16.3) yrs. and healthy (N=12) mean age 49.2(10.2) yrs. COMP
and CS846 levels were analyzed were measured using Elisa
assays (AnaMar Medical & IBEX Technologies Inc.).
Results: There was a statistically signiﬁcant difference in both
serum CS846 (p=0.01) and COMP (p =0.039) values between
the three groups as displayed in Figures 1 & 2.
CS846 levels were signiﬁcantly higher in OA patients vs. healthy
Figure 1. CS846 value in ACL, Normal and OA groups.
